Five Prime Thera
(FPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 12-2011 | |
| Sales | 3,549 | 2,975 | 0 | 2,862 | 0 |
| Gross Profit | 3,549 | 2,975 | N/A | 2,862 | N/A |
| Operating Expenses | 10,971 | 10,322 | 0 | 8,767 | 0 |
| Operating Income | -7,422 | -7,347 | N/A | -5,905 | N/A |
| Other Income | 148 | 300 | 0 | 47 | 0 |
| Pre-tax Income | -7,274 | -7,047 | 0 | -5,858 | 0 |
| Net Income Continuous | -7,274 | -7,047 | N/A | -5,858 | N/A |
| Net Income | $-7,274 | $-7,047 | $N/A | $-5,858 | $N/A |
| EPS Basic Total Ops | -5.82 | -5.73 | N/A | -4.85 | N/A |
| EPS Basic Continuous Ops | -5.82 | -5.73 | N/A | -4.85 | N/A |
| EPS Diluted Total Ops | -5.82 | -5.73 | N/A | -4.85 | N/A |
| EPS Diluted Continuous Ops | -5.82 | -5.73 | N/A | -4.85 | N/A |
| EBITDA(a) | $-6,885 | $-6,820 | $N/A | $-5,905 | $N/A |